Robin Xing: China’s 20th Party Congress Commits to Growth

Robin Xing: China’s 20th Party Congress Commits to Growth

At the recent 20th Party Congress in China, policy makers made economic growth a top priority, but what are the roadblocks that may be of concern to global investors?


----- Transcript -----


Welcome to Thoughts on the Market. I'm Robin Xing, Morgan Stanley's Chief China Economist. Along with my colleagues, bringing you a variety of perspectives, today I will discuss the outlook for China after the 20th Party Congress. It's Friday, November 18th, at 8 a.m. in Hong Kong.


China's Communist Party convenes a national Congress every five years to unveil mid to long term policy agenda and reshuffle its leadership. The one concluded two weeks ago marks the 20th Congress since the party's founding in 1921. One of the key takeaways is that economic growth remains the Chinese government's top priority, even as national security and the supply chain self-sufficiency have gained more importance. The top leadership's goal is to grow China to an income level on par with medium developed country by 2035. We think this suggests a per capita GDP target of $20,000, up from $12,000 today, and it would require close to 4% average growth in GDP in the coming decade.


Well, this growth target is achievable, but only with continued policy focus on growth. While China's economy has grown 6.7% a year over the last decade, its potential growth has likely entered a downward trajectory, trending toward 3% at the end of this decade, there is aging of the Chinese population, which is a main structure headwind. That could reduce labor input and the pace of capital accumulation. Meanwhile, productivity growth might also slow as geopolitical tensions increase the trend towards what Morgan Stanley terms slowbalization. The result of which is reduced foreign direct investment, particularly among sectors considered sensitive to national security. In this context, we believe Beijing will remain pragmatic in dealing with geopolitical tensions because of its reliance on key commodities and the fact exports account for a quarter of Chinese employment. So China is very intertwined with global economy and it relies a lot on the access to global market.


Another issue of concern to global investors is China's regulatory reset since 2020 and its impact on the private sector. It seems to have entered a more stable stage. We don't expect major regulatory surprises from here considering that the party Congress didn't identify any new areas with major challenges domestically, except for population aging and the self-sufficiency of supply chain.


As investors adopt a "seeing is believing" mentality towards their long term concerns around China's growth, policy, geopolitics, the more pressing near-term risk remains COVID zero. This is likely the biggest overhang on Chinese economic growth and the news flow around reopening have tended to trigger market volatility. We see rising urgency for an exit from COVID zero in the context of its economic cost, including lower income growth, elevated youth unemployment and even fiscal sustainability risks. We think Beijing will likely aim for a calibrated COVID exit, and the three key signposts are necessary to facilitate a smooth reopening, elderly vaccination, availability of domestic COVID treatment pills and facilities, and continued effort to steer public opinion away from fear of the virus.


Considering it could take 3 to 6 months for the key signposts to play out, we expect a full reopening next spring at the earliest. This underpins our forecast of a modest recovery starting in the second quarter of 2023, led by private consumption. Before a full reopening, we see growth continue to muddle through at the subpar level, sustained mainly by public CapEx.


Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Avsnitt(1515)

Special: Access & Opportunity Preview

Special: Access & Opportunity Preview

Morgan Stanley's Carla Harris talks with Charles Hudson, founder and Managing Partner at Precursor Ventures, a seed-stage investor bringing an institutional perspective to startups in the earliest stages of their development.

26 Juli 20194min

Michael Zezas: The Fed Rate Cut Debate for Bond Investors

Michael Zezas: The Fed Rate Cut Debate for Bond Investors

On today’s podcast, Head of Public Policy and Municipal Strategy Michael Zezas considers the debate between the consensus view of a potential 25 basis point Fed rate cut vs a 50 basis point cut.

24 Juli 20192min

Mike Wilson: Weighing a Potential Fed Rate Cut

Mike Wilson: Weighing a Potential Fed Rate Cut

On today’s podcast, Chief Investment Officer Mike Wilson says what matters for markets now isn't how much the Fed or other central banks could cut—but why they would cut.

22 Juli 20193min

Andrew Sheets: 3 Consensus Views Worth Questioning

Andrew Sheets: 3 Consensus Views Worth Questioning

On today’s podcast, Chief Cross-asset Strategist Andrew Sheets digs into three key debates around central bank policy expectations, valuations and investor sentiment.

19 Juli 20194min

Michael Zezas: 2020 Election: How Likely Is Medicare-for-All?

Michael Zezas: 2020 Election: How Likely Is Medicare-for-All?

On today’s podcast, Head of U.S. Public Policy research Michael Zezas asks “Would a Democratic presidential win mean the end of the road for private health care insurance?

17 Juli 20192min

Mike Wilson: For the S&P 500, Breaking Out Is Hard to Do

Mike Wilson: For the S&P 500, Breaking Out Is Hard to Do

On today’s podcast, Chief Investment Officer Mike Wilson says a sustained breakout above 3,000 has eluded the S&P 500. Will the Fed’s potential rate cut be the catalyst?

15 Juli 20194min

Andrew Sheets: A Second (and Third) Opinion for Equity Markets

Andrew Sheets: A Second (and Third) Opinion for Equity Markets

On this episode, Chief Cross-Asset Strategist Andrew Sheets examines the models for stock performance, and how they are all leading to a similar conclusion.

12 Juli 20194min

Michael Zezas: Healthcare Reform - Here We Go Again?

Michael Zezas: Healthcare Reform - Here We Go Again?

On today’s podcast, as the 2020 Election nears, healthcare reform is a central debate once again. Head of U.S. Public Policy Michael Zezas shares potential outcomes for patients—and investors.

10 Juli 20192min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
uppgang-och-fall
rss-svart-marknad
lastbilspodden
fill-or-kill
avanzapodden
rss-kort-lang-analyspodden-fran-di
affarsvarlden
rss-dagen-med-di
24fragor
borsmorgon
rss-inga-dumma-fragor-om-pengar
kapitalet-en-podd-om-ekonomi
bathina-en-podcast
market-makers
svd-tech-brief